DCGO vs DOCS vs HIMS vs WELL

For growth investors, DocGo Inc.

(DCGO) is the stronger pick with 522574% revenue growth year-over-year, versus 20. 0% for Doximity, Inc. (DOCS). Doximity, Inc. (DOCS) offers the better valuation at 23. 5x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate Doximity, Inc. (DOCS) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Doximity, Inc.

(DOCS) is the cheapest at 23. 5x versus Welltower Inc. at 153. 3x. On forward P/E, Doximity, Inc. is actually cheaper at 16. 8x.

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -93. 6% for DocGo Inc. (DCGO). Over 10 years, the gap is even starker: WELL returned +223. 1% versus DCGO's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Welltower Inc.

(WELL) is the lower-risk stock at 0. 13β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 1707% more volatile than WELL relative to the S&P 500. On balance sheet safety, Doximity, Inc. (DOCS) carries a lower debt/equity ratio of 1% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), DocGo Inc.

(DCGO) is pulling ahead at 522574% versus 20. 0% for Doximity, Inc. (DOCS). On earnings-per-share growth, the picture is similar: Doximity, Inc. grew EPS 54. 2% year-over-year, compared to -1122. 2% for DocGo Inc.. Over a 3-year CAGR, DCGO leads at 89. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Doximity, Inc.

(DOCS) is the more profitable company, earning 39. 1% net margin versus -56. 6% for DocGo Inc. — meaning it keeps 39. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOCS leads at 39. 9% versus -55. 3% for DCGO. At the gross margin level — before operating expenses — DOCS leads at 90. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Doximity, Inc.

(DOCS) trades at 16. 8x forward P/E versus 78. 4x for Welltower Inc. — 61. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DOCS: 64. 4% to $42. 79.

In this comparison, WELL (1.

3% yield) pays a dividend. DCGO, DOCS, HIMS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Welltower Inc.

(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). DocGo Inc. (DCGO) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WELL: +223. 1%, DCGO: -93. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DCGO (Healthcare) and DOCS (Healthcare) and HIMS (Healthcare) and WELL (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

WELL pays a dividend while DCGO, DOCS, HIMS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.